Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experience

European Journal of Cancer

Volumn 48, Issue 4, 2012, Pages 492-500

  Kang, Myoung Joo ^a,b   Ryoo, Baek Yeol ^a   Ryu, Min Hee ^a   Koo, Dong Hoe ^a   Chang, Heung Moon ^a   Lee, Jae Lyun ^a   Kim, Tae Won ^a   Kang, Yoon Koo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Advanced gastric cancer (AGC); Incidence rate; Overall survival; Prognosis; Venous thromboembolism (VTE)

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; CA 19-9 ANTIGEN; CETUXIMAB; CISPLATIN; FLUOROURACIL; HEPARIN; IRINOTECAN; LOW MOLECULAR WEIGHT HEPARIN; OXALIPLATIN; TAXANE DERIVATIVE; WARFARIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASIAN; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CAUCASIAN; CLINICAL FEATURE; FEMALE; HUMAN; INCIDENCE; INOPERABLE CANCER; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STOMACH CANCER; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84857039748     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.11.016     Document Type: Article

References (32)

1. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 10 2007 2339 2346 (Pubitemid 350100757)
2. J.A. Heit, M.D. Silverstein, and D.N. Mohr Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 6 2000 809 815 (Pubitemid 30165241)
3. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 6 2005 715 722 (Pubitemid 40216041)
4. P.D. Stein, A. Beemath, and F.A. Meyers Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 1 2006 60 68 (Pubitemid 43117468)
5. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 4 2006 458 464
6. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 3 2007 632 634 (Pubitemid 46680709)
7. H.T. Sørensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 25 2000 1846 1850 (Pubitemid 32104130)
8. A. Varki Trousseau's syndrome: multiple definitions and multiple mechanisms Blood 110 6 2007 1723 1729 (Pubitemid 47443881)
9. P. Prandoni, A. Falanga, and A. Piccioli Cancer and venous thromboembolism Lancet Oncol 6 6 2005 401 410 (Pubitemid 40753746)
10. B. Furie, and B.C. Furie Mechanisms of thrombus formation N Engl J Med 359 9 2008 938 949
11. N. Levitan, A. Dowlati, and S.C. Remick Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using medicare claims data Medicine (Baltimore) 78 5 1999 285 291 (Pubitemid 29439263)
12. A.A. Khorana, C.W. Francis, and E. Culakova Thromboembolism in hospitalized neutropenic cancer patients J Clin Oncol 24 3 2006 484 490 (Pubitemid 46630468)
13. T.C. Haddad, and E.W. Greeno Chemotherapy-induced thrombosis Thromb Res 118 5 2006 555 568 (Pubitemid 44414957)
14. D. Cunningham, N. Starling, and S. Rao Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 1 2008 36 46
15. M. Dank, J. Zaluski, and C. Barone Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1st-line advanced gastric cancer patients J Clin Oncol 23 16S 2005 4003
16. E.D. Tetzlaff, A.M. Correa, and R. Komaki Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction Dis Esophagus 21 7 2008 575 581
17. E. Van Cutsem, V.M. Moiseyenko, and S. Tjulandin Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol 24 31 2006 4991 4997 (Pubitemid 46631401)
18. K.W. Lee, S.M. Bang, and S. Kim The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer J Thromb Haemost 8 3 2010 540 547
19. E.D. Tetzlaff, A.M. Correa, J. Baker, J. Ensor, and J.A. Ajani The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma Cancer 109 10 2007 1989 1995 (Pubitemid 46744192)
20. N. Starling, S. Rao, and D. Cunningham Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group J Clin Oncol 27 23 2009 3786 3793
21. R.H. White The epidemiology of venous thromboembolism Circulation 107 23 Suppl. 1 2003 I4 I8
22. R.H. White, H. Zhou, and P.S. Romano Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California Ann Intern Med 128 9 1998 737 740 (Pubitemid 28204865)
23. A.L. Klatsky, M.A. Armstrong, and J. Poggi Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans Am J Cardiol 85 11 2000 1334 1337 (Pubitemid 30314667)
24. P.M. Ridker, J.P. Miletich, C.H. Hennekens, and J.E. Buring Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening JAMA 277 16 1997 1305 1307 (Pubitemid 27194355)
25. J.P. Gregg, A.J. Yamane, and W.W. Grody Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations Am J Med Genet 73 3 1997 334 336 (Pubitemid 27509913)
26. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 23 Suppl. 1 2003 I17 I21
27. A.A. Khorana, and G.C. Connolly Assessing risk of venous thromboembolism in the patient with cancer J Clin Oncol 27 29 2009 4839 4847
28. R.S. Komrokji, N.P. Uppal, and A.A. Khorana Venous thromboembolism in patients with diffuse large B-cell lymphoma Leuk Lymphoma 47 6 2006 1029 1033
29. M. Mandalà, M. Reni, and S. Cascinu Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients Ann Oncol 18 10 2007 1660 1665 (Pubitemid 47506252)
30. S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 4 2002 575 579 (Pubitemid 34302943)
31. G. Numico, O. Garrone, and V. Dongiovanni Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine Cancer 103 5 2005 994 999 (Pubitemid 40270076)
32. S.E. Al-Batran, J.T. Hartmann, and S. Probst Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie J Clin Oncol 26 9 2008 1435 1442